CEO Dr. Hanadie Yousef featured on Biotech TV’s Biotech CEO Sisterhood series at the NYSE, spotlighting Juvena’s leadership in protein-based therapeutics for muscle and metabolic disease
CEO Dr. Hanadie Yousef delivered a seminar at the Buck Institute as a distinguished guest speaker highlighting Juvena’s pioneering work in regenerative biologics and AI-driven drug discovery
Juvena Therapeutics presented JUV-161 and JUV-112, at ENDO2025, earning recognition from the Endocrine Society for innovation in metabolic and endocrine health
Dr. Hanadie Yousef participates in the World Economic Forum’s Innovator Communities Meeting and Global Technology Retreat- and shares her expert insights on 2 panels: “Breaking Barriers: Funding Frontier Tech” and “Innovation to Impact: Commercialization Insights from the Field”
CEO Dr. Hanadie Yousef discusses how the success of GLP-1/GIP receptor agonists is reshaping the treatment of chronic metabolic diseases and driving the next wave of therapeutics targeting the biology of aging at BIO 2025 in Boston
